Comprehensive Transcriptional Analysis of Early-Stage Urothelial CarcinomaJakob Hedegaard, Lars Dyrskjøt, Niels Harving et al.|Cancer Cell|2016Cited by 654
Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder CarcinomaEmil Christensen, Lars Dyrskjøt, Karin Birkenkamp‐Demtröder et al.|Journal of Clinical Oncology|2019Cited by 540
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancerSia V. Lindskrog, Lars Dyrskjøt, Frederik Prip et al.|Nature Communications|2021Cited by 381
Clinical Implications of Monitoring Circulating Tumor DNA in Patients with Colorectal CancerLone V. Schøler, Claus L. Andersen, Thomas Reinert et al.|Clinical Cancer Research|2017Cited by 305
Cellular Disposal of miR23b by RAB27-Dependent Exosome Release Is Linked to Acquisition of Metastatic PropertiesMarie S. Ostenfeld, Torben F. Ørntoft, Dennis K. Jeppesen et al.|Cancer Research|2014Cited by 297